Summary
The product Winstrol 25 mg, from an Axle Labs manufacturer, underwent independent testing to determine its concentration and authenticity. The sample, identified by batch number 010, was submitted by Axle Labs and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Stanozolol, with concentrations ranging between 28.62 mg, 30.98 mg, and 32.00 mg, indicating that the dosage is above the labeled claim of 25 mg.
The testing process began on 27 December 2024, with the sample received on 31 December 2024, and the analysis completed on 07 January 2025. The results confirm that the product contains Stanozolol at higher-than-labeled concentrations, suggesting potential variability in formulation. While this batch exhibits strong potency, continued independent testing remains essential to ensure consistency across multiple batches. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Axle Labs
- Product Name: Winstrol 25 mg
- Active Ingredient: Stanozolol
- Batch Number: 010
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #55096
- Testing Ordered: 27 December 2024
- Sample Received: 31 December 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Axle Labs (manufacturer)
- Analysis Paid For By: Axle Labs (manufacturer)
Testing Results
- Specification: 25 mg (as stated on the label)
- Measured Concentration:
- 28.62 mg
- 30.98 mg
- 32.00 mg
- Accuracy: Ranges from 114.48% to 128.00% (14.48% – 28.00% above the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/55096_DPZ1PGQ64BFJ
Evaluation of Manufacturer-Submitted Testing
The analysis confirms that the Winstrol 25 mg sample contains Stanozolol in a range between 28.62 mg and 32.00 mg, exceeding the labeled dosage by 14.48% to 28.00%. While the presence of the active ingredient is verified, the variation in measured dosages suggests potential inconsistencies in manufacturing quality control.
Since the manufacturer remains Axle Labs, independent third-party testing across multiple batches is recommended to ensure product reliability. Janoshik Analytical follows strict transparency and quality control protocols, but additional testing would help determine the overall consistency of this formulation.
Conclusion
The analysis verifies that Winstrol 25 mg contains higher-than-labeled concentrations of Stanozolol, ranging between 28.62 mg and 32.00 mg. While the higher potency may be beneficial for some users, the variability in concentration raises concerns about batch consistency and accuracy in dosing. This report is published to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. The analysis results are based on a single sample, and variations between batches may exist. Since the manufacturer is Axle Labs, independent verification from additional third-party laboratories is strongly encouraged. Readers should use this information responsibly and consult professional guidance when assessing pharmaceutical products.
